Staar Low-Grade Serous Ovarian Cancer
Staar exists to advocate for and raise funds for research specifically on the low-grade serous carcinoma sub-type of ovarian cancer in the unted states. Throughout the year, we drove awareness of the symptoms of ovarian cancer and the under-funding of research for the lgsc sub-type. We make connections with researchers and ultimately have made three grants, soome with funds raised in 2021.
Staar Low-Grade Serous Ovarian Cancer at a glance
- Total assets
- $464,353
- +3.7% vs 2023
- Revenue (2024)
- $299,828
- -25.0% vs 2023
- Net investment income (2024)
- $364
- +8.0% vs 2023
- Expenses (2024)
- $56,165
- -79.7% vs 2023
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated September 2026.
Who Staar Low-Grade Serous Ovarian Cancer funds
How this funder distributes its grants
Grant Size Distribution
5 grants across all recorded years
The most common grant size was in the $100–250K range: 3 grants of 5 (60%).
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2022 to 2023, annual grant giving ranged from $153K (2023) to $339K (2022). In 2023 it made 2 grants totaling $153K.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| University of Oklahoma Health Systems Oklahoma City, OK | — | $100,000 |
| The University of Texas MD Anderson Cancer Center Houston, TX | Research on Low | $53,000 |
Ready to take the next step with Staar Low-Grade Serous Ovarian Cancer?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $464,353 | $299,828 | $56,165 | — | — | $364 |
| 2023 | $448,000 | $399,588 | $277,067 | $153,000 | 2 | $337 |
| 2022 | $164,305 | $310,800 | $513,766 | $338,500 | 3 | — |
| 2021 | $229,771 | $168,253 | $32,865 | — | — | — |
| 2020 | $94,383 | $96,688 | $2,305 | — | — | — |
About Staar Low-Grade Serous Ovarian Cancer
Based on IRS filings
Staar Low-Grade Serous Ovarian Cancer is a public charity focused on Medical Research, based in Chicago, IL. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $464K in total assets. Net investment income was $364.
Focus Areas
Leadership & Key People
Officers and directors from IRS filings
Staar Low-Grade Serous Ovarian Cancer is led by Nicole Andrews, Chair on every filing since 2021; none of the 11 officers listed in 2024 report compensation.
Officers on the 2024 filing
Nicole Andrews
Chair
On filings since 2021
9 hrs/week
No compensation reported
Alyssa Toomes
V-Chair Fund
On filings since 2023
3 hrs/week
No compensation reported
Kari Neumeyer
V-Chair Mark
On filings since 2023
10 hrs/week
No compensation reported
Bailey Wolfe
Director
Secretary → Member, 2021
Member → Director, 2023
On filings since 2020
1 hr/week
No compensation reported
Emma Schlamm
Director
Vice Chair Marketing & Communications → Director, 2023
On filings since 2022
2 hrs/week
No compensation reported
Ellie Habib
Director
On filings since 2023
1 hr/week
No compensation reported
Connie Bell
Director
New on the 2024 filing
8 hrs/week
No compensation reported
Mark Blake
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Tiffany Locke
Director
New on the 2024 filing
1 hr/week
No compensation reported
Morgan Gaynor
Secretary
On filings since 2021
3 hrs/week
No compensation reported
Christina Campbell
Treasurer
On filings since 2023
3 hrs/week
No compensation reported
Former officers (6)
- Former: Madalyn Kenney (2023) — Director
- Former: Nicholas Gilbertson (2020–2022) — Vice Chair Funds
- Former: Solange Velasquez (2021–2022) — Treasurer
- Former: Alexandra Feldt (2020) — Vice President
- Former: Jessica BeCraft (2020) — President
- Former: Solange-Marie Velazquez (2020) — Treasurer
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Frequently asked questions about Staar Low-Grade Serous Ovarian Cancer
How large is Staar Low-Grade Serous Ovarian Cancer?
Staar Low-Grade Serous Ovarian Cancer reported $464K in total assets on its 2024 IRS Form 990. Its revenue that year was $300K.
What is Staar Low-Grade Serous Ovarian Cancer?
Staar Low-Grade Serous Ovarian Cancer is a public charity focused on Medical Research, based in Chicago, IL. It holds $464K in total assets as of 2024.
Where does Staar Low-Grade Serous Ovarian Cancer operate?
Staar Low-Grade Serous Ovarian Cancer has awarded grants in New York, Oklahoma, Texas.
What is Staar Low-Grade Serous Ovarian Cancer's EIN?
Staar Low-Grade Serous Ovarian Cancer's EIN (Employer Identification Number) is 84-4672869. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated September 2026. Sourced from IRS Form 990 filings.
Data update history
(4)
When this profile's IRS filing data changed on Grantable
- Updated Form 990-EZ for fiscal year 2020 (received by the IRS May 11, 2023)
- Updated Form 990 for fiscal year 2022 (received by the IRS May 13, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS September 18, 2024)
- IRS filings on file for fiscal years 2020–2024
Live grants for the work Staar Low-Grade Serous Ovarian Cancer funds
Medical Research Open opportunities, soonest deadline first.
- 2026 USS Translational Research Grant Up to $100,000 per year · Due October 24, 2026
- Dr. Richard A. Falls Virginia Lions Eye Institute Research Grant Up to $40,000 (yearly total budget) · Due October 25, 2026
- NSF Graduate Research Fellowship Program (GRFP) $32,000 annually plus $12,000 cost of education allowance · Due October 27, 2026
Explore Open Grants
Browse active grant opportunities in Staar Low-Grade Serous Ovarian Cancer's focus areas in our free grants database
Similar Funders
Funders with grantees in common
Greater New York Hospital Foundation Inc
New York, NY
The foundation's mission is to identify and implement innovative solutions to challenges facing the health care system in order to increase access and promote the delivery of quality health care for the underserved. For more information,
Assets
$1.3M
Grants
1
Total Given
$20K
Kidney Cancer Research Alliance Inc
Alexandria, VA
Kccure is a patient-driven, evidence-based, kidney cancer advocacy organization dedicated to improving outcomes through outreach, reasearch and education.
Assets
$941K
Grants
2
Total Given
$75K
Think Pink Rocks Inc
Boca Raton, FL
Raise awareness about early detection of genetic testing for breast cancer, and to provide funding for research.
Assets
$151K
Grants
3
Total Given
$436K
Brave Like Gabe Foundation
Minneapolis, MN
The mission of the Brave Like Gabe Foundation is to support rare cancer research and empower all cancer survivors through physical activity.
Assets
$683K
Grants
4
Total Given
$109K
The Bluefield Project to Cure Frontotemporal Dementia
San Francisco, CA
frontal lobe of the brain and may extend back to the temporal lobe. FTD is the second most common early-onset dementia after Alzheimer's disease.
Assets
$13.2M
Grants
5
Total Given
$3.4M
American Institute for Cancer Research
Arlington, VA
Aicr champions the latest and most authoritative scientific research from around the world on cancer prevention and survival through diet, weight and physical activity, so that we can help people make informed lifestyle choices to reduce their cancer risk.
Assets
$17.8M
Grants
7
Total Given
$1.2M
More similar funders
More Funders in Illinois
The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open
Figures come from Staar Low-Grade Serous Ovarian Cancer's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Staar Low-Grade Serous Ovarian Cancer down — hundreds of funders to go?